Effects of different interchain linkers on biological activity of an anti-prostate cancer single-chain bispecific antibody.

Background A single-chain bispecific antibody (scBsAb; an engineered antibody), has promising clinical applications. Nonetheless, the effect of different interchain linkers on its activity is poorly understood.